Search
for
Sort by
Research 31–60 of 1000+
- Cutaneous Drug Eruptions Associated with the Use of New Oncological Drugs
- Dermatologic Reactions to Targeted Therapy
- Hyperpigmentation, severe alopecia, and six days of instability in a case of severe methotrexate hypersensitivity reaction
- Cutaneous manifestations associated with immune checkpoint inhibitors
- Cutaneous adverse reactions linked to targeted anticancer therapies bortezomib and lenalidomide for multiple myeloma: new drugs, old side effects
- Eosinophilic Fasciitis Associated With Tryptophan Ingestion
- Dermatological aspects of the S2k guidelines on Down syndrome in childhood and adolescence
- COVID-19 pandemic and teledermatology in low-income regions
- Diseases of the skin. Drug ill effects on the skin.
- Caution in the time of rashes and COVID-19
- Skin amidst COVID ‐19 pandemic
- Skin Manifestations in Confirmed COVID 19 Patients; A Short Prospective Multicenter Case Series Cohort Study
- Skin Manifestations of Targeted Antineoplastic Therapy
- H12 Royal rashes: a potted dermatology history in the British monarchy
- Urticaria, Drug Hypersensitivity Rashes, Nodules and Tumors, and Atrophic Diseases
- Continuous MEK inhibition by AZD6244 (ARRY-142886) results in exhaustion of the cutaneous keratinocytic stem cell pool and resembles senescence driven skin aging
- Prevalence and Pattern of Skin Manifestations in COVID-19 Patients; A Cross-Sectional Observational Study in Saudi Arabia
- Data from Tumor Necrosis Factor-α and Interleukin-1 Antagonists Alleviate Inflammatory Skin Changes Associated with Epidermal Growth Factor Receptor Antibody Therapy in Mice
- Rare and common manifestations of COVID‐19 in children
- Postgraduate seminar in pediatric dermatology
- Dermatolojik Problemler ve COVID-19
- Dermatological history and examination
- Overview of COVID-19 and Its Vaccination and Its Relation to Dermatology
- Dermatologic adverse events associated with chemotherapy and targeted anticancer therapy
- Cutaneous toxicities of new targeted cancer therapies: must know for diagnosis, management, and patient-proxy empowerment
- Cutaneous Toxicities of Advanced Treatment for Cutaneous Melanoma: A Prospective Study from a Single-Center Institution
- Skin Manifestations in Confirmed COVID 19 Patients; A Short Prospective Multicenter Case Series Cohort Study
- Novel acquisitions on the immunoprotective roles of the EGF receptor in the skin
- Multibacillary leprosy with positive serology misdiagnosed as systemic lupus erythematosus
- Recent advances in the epidermal growth factor receptor/ligand system biology on skin homeostasis and keratinocyte stem cell regulation